The Literature

Cost-Effectiveness of MIGS Procedures and Devices

Recent research sheds light on the economics of combined procedures and technologies.

Christopher Teng, MD, MBA

The Literature

The Impact of Diet on Glaucoma Risk

Simple recommendations on nutrition could make a significant difference in patients’ health.

Jeffrey R. SooHoo, MD, MBA, and Monica Ertel, MD, PhD

The Literature

Outcomes With Glaucoma Drainage Devices

Two studies evaluated success rates and factors.

Tala Al-Khaled, MD; Abenet Michael, MD; and Ahmad A. Aref, MD, MBA

The Literature

Monitoring Ocular Hypertension

Balancing patients’ preferences with cost-effective care.

Almiqdad Saeed, MD; Rithambara Ramachandran, MD, MSc; and Lama A. Al-Aswad, MD, MPH

The Literature

The Ophthalmology Workforce the United States Needs

Two studies assessed critical concerns about eye care delivery, the current ophthalmology workforce, and interventions to decrease the number of missed clinic appointments.

O’Rese J. Knight, MD, and Angela R. Elam, MD, MPH

The Literature

Disparities in Glaucoma Care

Two studies analyzed demographic differences.

Ricardo Salinas, MD

The Literature

Glucagon-Like Peptide-1 Receptor Agonists

Studies evaluated the effects of these drugs on IOP and glaucoma.

Vivian L. Qin, MD, and Victoria L. Tseng, MD, PhD

The Literature

Detecting Disease Progression

Studies assessed whether deep learning models and IOP fluctuation could provide clues that glaucoma would rapidly become more severe.

Julius T. Oatts, MD, and Ying Han, MD, PhD

The Literature

Optimizing Surgical Technique

Studies sought to determine the best protocols for two procedures.

Yvonne Okaka, MD, and Charles A. Cole, MD

The Literature

Schlemm Canal Microstenting

Recent updates on MIGS combined with phacoemulsification.

Jon Williams, MD, and Manjool Shah, MD

The Literature

The Incidence of Endophthalmitis After MIGS

Looking for risk factors and differences among procedures.

Sayyada (Maela) Hyder, MD, and Sarah H. Van Tassel, MD

The Literature

IOL Selection and Glaucoma

The effects of certain lenses on the disease and patients’ visual outcomes.

Luke Barnard, MD, and Christopher Teng, MD, MBA

The Literature

When and How to Treat Glaucoma

Randomized trials evaluated the effects of medical, laser, and surgical intervention.

Deidre St. Peter, MD, and Cara E. Capitena Young, MD

The Literature

When to Perform a Peripheral Iridotomy

The procedure may not benefit all patients with angle closure, but it plays an important role in some cases.

Alanna James, MD, and Benjamin Y. Xu, MD, PhD

The Literature

Lessons in Nonsurgical Glaucoma Management

Should SLT be performed as the initial treatment for glaucoma and ocular hypertension?

Jiun Lap Do, MD, PhD, and Naimul Alam, MD

The Literature

Visual Field Outcomes of Two Major Glaucoma Trials

Moving beyond IOP reductions measured in the clinic.

Sophia Y. Wang, MD, MS, and Robert T. Chang, MD

The Literature

When Glaucoma Therapy Fails

Recent studies highlight the risks and benefits of two interventions for refractory glaucoma.

Tanner J. Frediani, BS, and Brian J. Song, MD, MPH

The Literature

Factors in Disease Progression

Researchers evaluated the effects of blood pressure and laser peripheral iridotomy on glaucoma.

Harrison Bannett, DO, and Christopher C. Teng, MD

The Literature

Incorporating New Visual Field Protocols

Recent evidence supports the clinical utility of new visual field testing protocols that are faster and more comprehensive.

James C. Tsai, MD, MBA; Ali M. Allahdina, MD; and Thasarat Sutabutr Vajaranant, MD, MHA